Literature DB >> 28733082

Effects of novel triple-stage antimalarial ionic liquids on lipid membrane models.

Ricardo Ferraz1, Marina Pinheiro2, Ana Gomes1, Cátia Teixeira1, Cristina Prudêncio3, Salette Reis2, Paula Gomes4.   

Abstract

Primaquine-based ionic liquids, obtained by acid-base reaction between parent primaquine and cinnamic acids, were recently found as triple-stage antimalarial hits. These ionic compounds displayed significant activity against both liver- and blood-stage Plasmodium parasites, as well as against stage V P. falciparum parasites. Remarkably, blood-stage activity of the ionic liquids against both chloroquine-sensitive (3D7) and resistant (Dd2) P. falciparum strains was clearly superior to those of the respective covalent (amide) analogues and of parent primaquine. Having hypothesized that such behaviour might be ascribed to an enhanced ability of the ionic compounds to permeate into Plasmodium-infected erythrocytes, we have carried out a differential scanning calorimetry-based study of the interactions between the ionic liquids and membrane models. Results provide evidence, at the molecular level, that the primaquine-derived ionic liquids may contribute to an increased permeation of the parent drug into malaria-infected erythrocytes, which has relevant implications towards novel antimalarial approaches based on ionic liquids.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ionic liquids; Liposomes; Malaria; Primaquine; Red Blood Cells

Mesh:

Substances:

Year:  2017        PMID: 28733082     DOI: 10.1016/j.bmcl.2017.07.006

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  In Vitro Anti-Toxoplasma gondii and Antimicrobial Activity of Amides Derived from Cinnamic Acid.

Authors:  Graziela Rangel Silveira; Karoline Azerêdo Campelo; Gleice Rangel Silveira Lima; Lais Pessanha Carvalho; Solange Silva Samarão; Olney Vieira-da-Motta; Leda Mathias; Carlos Roberto Ribeiro Matos; Ivo José Curcino Vieira; Edesio José Tenório de Melo; Edmilson José Maria
Journal:  Molecules       Date:  2018-03-28       Impact factor: 4.411

Review 2.  Primaquine derivatives: Modifications of the terminal amino group.

Authors:  Branka Zorc; Ivana Perković; Kristina Pavić; Zrinka Rajić; Maja Beus
Journal:  Eur J Med Chem       Date:  2019-08-23       Impact factor: 6.514

Review 3.  Cinnamic Acid Conjugates in the Rescuing and Repurposing of Classical Antimalarial Drugs.

Authors:  Ana Teresa Silva; Clara M Bento; Ana C Pena; Luísa M Figueiredo; Cristina Prudêncio; Luísa Aguiar; Tânia Silva; Ricardo Ferraz; Maria Salomé Gomes; Cátia Teixeira; Paula Gomes
Journal:  Molecules       Date:  2019-12-24       Impact factor: 4.411

Review 4.  The Role of Ionic Liquids in the Pharmaceutical Field: An Overview of Relevant Applications.

Authors:  Sónia N Pedro; Carmen S R Freire; Armando J D Silvestre; Mara G Freire
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

5.  Building on Surface-Active Ionic Liquids for the Rescuing of the Antimalarial Drug Chloroquine.

Authors:  Ana Teresa Silva; Lis Lobo; Isabel S Oliveira; Joana Gomes; Cátia Teixeira; Fátima Nogueira; Eduardo F Marques; Ricardo Ferraz; Paula Gomes
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

6.  Insights into the Membranolytic Activity of Antimalarial Drug-Cell Penetrating Peptide Conjugates.

Authors:  Luísa Aguiar; Marina Pinheiro; Ana Rute Neves; Nuno Vale; Sira Defaus; David Andreu; Salette Reis; Paula Gomes
Journal:  Membranes (Basel)       Date:  2020-12-22

Review 7.  Looking beyond Typical Treatments for Atypical Mycobacteria.

Authors:  Clara M Bento; Maria Salomé Gomes; Tânia Silva
Journal:  Antibiotics (Basel)       Date:  2020-01-03

8.  "Clicking" an Ionic Liquid to a Potent Antimicrobial Peptide: On the Route towards Improved Stability.

Authors:  Ana Gomes; Lucinda J Bessa; Patrícia Correia; Iva Fernandes; Ricardo Ferraz; Paula Gameiro; Cátia Teixeira; Paula Gomes
Journal:  Int J Mol Sci       Date:  2020-08-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.